|

TVMR With the INNOVALVE System Trial - Early Feasibility Study

RECRUITINGN/ASponsored by Edwards Lifesciences
Actively Recruiting
PhaseN/A
SponsorEdwards Lifesciences
Started2022-09-01
Est. completion2026-07-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations20 sites

Summary

Study to evaluate the safety and performance of the INNOVALVE system

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Clinically significant, symptomatic mitral regurgitation
* High risk for open-heart surgery
* Meets anatomical criteria

Exclusion Criteria:

* Unsuitable anatomy
* Patient is inoperable
* EF\<25%

Conditions2

Heart DiseaseMitral Valve Regurgitation (Degenerative or Functional)

Locations20 sites

Cedars-Sinai
Mitch Gheorghiu310-407-9553Mitch.Gheorghiu@cshs.org
Stanford University
Palo Alto, California, 94305
Anushka Marathe650-497-0903amarathe@stanford.edu
Naples Comprehensive Health
Naples, Florida, 34102
Kathy Byrd239-624-8113kathy.byrd@nchmd.org
Emory University
Elizabeth Charles404-686-1249echarl2@emory.edu
Piedmont Heart Institute
Jennifer Bolivar Aldana770-846-0344jennifer.bolivaraldana@piedmont.org

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.